Market Whales and Their Recent Bets on VKTX Options
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), as revealed by Benzinga's options scanner. The significant options activity includes 4 puts totaling $799,745 and 9 calls amounting to $315,579, with 76% of the sentiment being bearish. The stock is currently trading at $63.27, up by 0.83%, with an RSI suggesting it may be approaching oversold. Analysts have mixed ratings with a consensus target price of $118.0.
May 28, 2024 | 6:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Deep-pocketed investors have shown a bearish sentiment towards Viking Therapeutics, with significant options activity indicating potential downward pressure on the stock. The stock is currently trading at $63.27, up by 0.83%, but the RSI suggests it may be approaching oversold territory. Analysts have mixed ratings with a consensus target price of $118.0.
The significant bearish options activity, with 76% of the sentiment being bearish, suggests potential downward pressure on VKTX's stock price. Despite the current price increase and mixed analyst ratings, the overall sentiment from large investors is a strong indicator of potential short-term decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100